Beacon Dx provides a diagnostic platform that identifies active viral persistence or reactivation—such as EBV, CMV, and HSV—that can drive ongoing Long COVID symptoms. Using its proprietary MENSA technology, the test distinguishes low‑level or intermittent viral activity that standard serology, PCR, or inflammation markers often miss, giving physicians clearer insight into the underlying cause of patients' chronic symptoms.
Funding
Funding not disclosed
Founders
Product
Problem
Current diagnostic tools such as standard serology, PCR, and generic inflammation markers cannot reliably detect low‑level or intermittent viral persistence or reactivation (e.g., EBV, CMV, HSV) that may underlie chronic Long COVID symptoms. This limitation leaves clinicians without clear evidence to guide treatment decisions for post‑viral patients.
Solution
Beacon Dx offers a specialized diagnostic service that identifies active viral persistence or reactivation using precision immunoassays integrated with the proprietary MENSA platform. The MENSA technology enhances assay sensitivity, enabling detection of low‑level viral activity that standard PCR often misses. Results are delivered as a detailed report indicating which latent viruses are currently active, providing physicians with actionable insight into the etiology of ongoing post‑viral illness. By focusing on specific viral reactivation rather than generic inflammation, the service supports more targeted therapeutic strategies for Long COVID and related chronic conditions.
Target Audience
Primary customers are physicians and healthcare providers managing patients with Long COVID or other chronic post‑viral syndromes who require precise identification of active viral contributors.
Features
- High‑sensitivity immunoassays capable of detecting low‑level EBV, CMV, and HSV activity
- Proprietary MENSA platform that amplifies assay signals for intermittent viral reactivation
- Comprehensive reports that differentiate between past exposure and current viral activity
- Integration with existing clinical workflows, delivering results in a format compatible with electronic health records
- Validation against standard serology and PCR to ensure clinical reliability